ರಕ್ತದ ಕ್ಯಾನ್ಸರ್ಗಳು: ಸ್ಟೆಮ್ ಸೆಲ್ ಟ್ರಾನ್ಸ್ಪ್ಲಾಂಟ್
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
ಎಲ್ಲಿಗೆ ಹೋಗಬೇಕು
ಈ trial ಗೆ 1 ಆಸ್ಪತ್ರೆ ರೋಗಿಗಳನ್ನು ಸೇರಿಸಿಕೊಳ್ಳುತ್ತಿದೆ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
Cyclophosphamide is the name of a medicine given to prevent graft-versus-host-disease (GVHD) after half-matched transplant. This medicine is given on the 3rd and 4th day after stem cell transplant. The standard dose of this medicine is 50 mg per kg of the patient's weight given on the 3rd and the 4th day. However, using this medicine at this dose of 50 mg / kg for 2 days is associated with certain problems such as susceptibility to infections and delay in the recovery of the immune system after stem cell transplant. Therefore, several research groups across the world have tried to reduce the d…
ಸ್ಪಾನ್ಸರ್: ಟಾಟಾ ಮೆಮೋರಿಯಲ್ ಸೆಂಟರ್
NCT07719946 on ClinicalTrials.gov
ಲಾಸ್ಟ್ ಅಪ್ಡೇಟೆಡ್ ಆನ್ ದ ರಿಜಿಸ್ಟ್ರಿ 22 Jul 2026 · ರೀಡ್ ಬೈ ಅಸ್ 20 Oct 2026